Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-OLD Trial: Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease
NCT05361421Phase 4Active, not recruiting
- Sponsor
- Yonsei University
- Start
- Jul 2022
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in cardiovascular disease (CVD) (2 arms), sponsored by Yonsei University. Primary endpoint: Clinical efficacy of intensive lipid-lowering therapy at 3 years. Started Jul 2022; status: active, not recruiting.
02
Drugs
atorvastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT05361421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05361421.